Anaphore

Recent Finacing

Equity

Recent Raise

$25M

Anaphore develops "artimers"—protein therapeutics derived from naturally secreted human serum proteins—for oncology and immune-disease indications, using a non-antibody platform designed for scalable manufacturing.